Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA genital shedding in U.S. and Kenyan Women

AIDS Research and Human Retroviruses

Volumn 29, Issue 1, 2013, Pages 13-19

  Mitchell, Caroline ^a   Balkus, Jennifer E ^b   Fredricks, David ^b,c   Liu, Congzhou ^c   McKernan Mullin, Jennifer ^d   Frenkel, Lisa M ^d   Mwachari, Christina ^e   Luque, Amneris ^f   Cohn, Susan E ^g   Cohen, Craig R ^h   Coombs, Robert ^b   Hitti, Jane ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^e KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^f UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ADULT; AFRICAN AMERICAN; ANTIVIRAL THERAPY; ATOPOBIUM; BACTERIAL COLONIZATION; BACTERIAL VAGINOSIS ASSOCIATED BACTERIA; BACTERIUM; CAUCASIAN; CD4 LYMPHOCYTE COUNT; FEMALE; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRAUTERINE CONTRACEPTIVE DEVICE; KENYA; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS JENSENII; LEPTOTRICHIA; LIMIT OF DETECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; MEGASPHAERA; NONHUMAN; ORAL CONTRACEPTION; PARITY; PELVIC EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; TRICHOMONAS VAGINALIS; UNITED STATES; UTERINE CERVICITIS; UTERINE TUBE LIGATION; VAGINA FLORA; VAGINAL LAVAGE; VAGINITIS; VIRUS DETECTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS SHEDDING;

ADOLESCENT; ADULT; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KENYA; LACTOBACILLUS; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL; UNITED STATES; VAGINA; VAGINOSIS, BACTERIAL; VIRUS SHEDDING; YOUNG ADULT;

EID: 84871877897     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0187     Document Type: Review

References (40)

1. Cu-Uvin S, DeLong AK, Venkatesh KK, et al.: Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. AIDS 2010;24(16):2489-2497.
2. Cummins JE, Christensen L, Lennox JL, et al.: Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load. AIDS Res Hum Retroviruses 2006;22(8):788-795.
3. Baeten JM, Kahle E, Lingappa JR, et al.: Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 2011;3(77):77ra29.
4. Haase AT: Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010;464(7286):217-223.
5. Salle B, Brochard P, Bourry O, et al.: Infection of macaques after vaginal exposure to cell-associated simian immunodeficiency virus. J Infect Dis 2010;202(3):337-344.
6. Pavlova SI, Kilic AO, Kilic SS, et al.: Genetic diversity of vaginal lactobacilli from women in different countries based on 16S rRNA gene sequences. J Appl Microbiol 2002;92(3): 451-459.
7. Zuckerman RA, Lucchetti A, Whittington WL, et al.: Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2- seropositive men: A randomized, double-blind, placebocontrolled crossover trial. J Infect Dis 2007;196(10):1500- 1508.
8. Boom R, Sol CJ, Salimans MM, et al.: Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28(3):495-503.
9. Coutlee F, He Y, Saint-Antoine P, Olivier C, and Kessous A: Coamplification of HIV type 1 and beta-globin gene DNA sequences in a nonisotopic polymerase chain reaction assay to control for amplification efficiency. AIDS Res Hum Retroviruses 1995;11(3):363-371.
10. Micek MA, Blanco AJ, Beck IA, et al.: Nevirapine resistance by timing of HIV type 1 infection in infants treated with singledose nevirapine. Clin Infect Dis 2010;50(10):1405-1414.
11. Nugent RP, Krohn MA, and Hillier SL: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29(2):297-301.
12. Luque AE, Hitti J, Mwachari C, et al.: Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: Results from the Women's HIV Interdisciplinary Network (WHIN). Int J Infect Dis 2010;14(9):e810-814.
13. Corey L, Huang ML, Selke S, and Wald A: Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay. J Med Virol 2005;76(3):350-355.
14. Mostad SB, Kreiss JK, Ryncarz AJ, et al.: Cervical shedding of cytomegalovirus in human immunodeficiency virus type 1-infected women. J Med Virol 1999;59(4):469-473.
15. Fredricks DN, Fiedler TL, Thomas KK, Mitchell CM, and Marrazzo JM: Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol 2009;47(3):721-726.
16. Srinivasan S, Liu C, Mitchell CM, et al.: Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One 2010;5(4):e10197.
17. Sterne JA, White IR, Carlin JB, et al.: Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. BMJ 2009;338:b2393.
18. Eschenbach DA, Patton DL, Meier A, et al.: Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium. Contraception 2000;62(3):107-112.
19. Fredricks DN, Fiedler TL, and Marrazzo JM: Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005;353(18):1899- 1911.
20. Martinez RC, Seney SL, Summers KL, Nomizo A, De Martinis EC, and Reid G: Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation. Microbiol Immunol 2009;53(9):487-495.
21. Sha BE, Zariffard MR, Wang QJ, et al.: Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 2005;191(1):25-32.
22. Anton G, Rid J, Mylonas I, Friese K, and Weissenbacher ER: Evidence of a TH1-shift of local vaginal inflammatory response during bacterial vaginosis. Infection 2008;36(2):147- 152.
23. Yudin MH, Landers DV, Meyn L, and Hillier SL: Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: A randomized trial. Obstet Gynecol 2003;102(3):527- 534.
24. Cu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH, and Carpenter CC: Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 2001;33(6): 894-896.
25. Rebbapragada A, Howe K, Wachihi C, et al.: Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. J Acquir Immune Defic Syndr 2008;49(5):520-522.
26. Anderson BL, Cu-Uvin S, Raker CA, Fitzsimmons C, and Hillier SL: Subtle perturbations of genital microflora alter mucosal immunity among low-risk pregnant women. Acta Obstet Gynecol Scand 2011;90(5):510-515.
27. Nikolaitchouk N, Andersch B, Falsen E, Strombeck L, and Mattsby-Baltzer I: The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: Application of checkerboard DNA-DNA hybridization (CDH). Apmis 2008;116(4):263-277.
28. Williams SA, Kwon H, Chen LF, and Greene WC: Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1. J Virol 2007;81(11):6043-6056.
29. Graham SM, Holte SE, Peshu NM, et al.: Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS 2007;21(4):501-507.
30. Cohen MS, Chen YQ, McCauley M, et al.: Prevention of HIV- 1 infection with early antiretroviral therapy. N Engl J Med 2011;365(6):493-505.
31. Henning TR, Kissinger P, Lacour N, Meyaski-Schluter M, Clark R, and Amedee AM: Elevated cervical white blood cell infiltrate is associated with genital HIV detection in a longitudinal cohort of antiretroviral therapy-adherent women. J Infect Dis 2010;202(10):1543-1552.
32. Gitau RW, Graham SM, Masese LN, et al.: Effect of acquisition and treatment of cervical infections on HIV-1 shedding in women on antiretroviral therapy. AIDS 2010; 24(17):2733-2737.
33. LeGoff J, Weiss HA, Gresenguet G, et al.: Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes. AIDS 2007;21(12):1569-1578.
34. Spinillo A, Zara F, Gardella B, Preti E, Mainini R, and Maserati R: The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions. Am J Obstet Gynecol 2005;192(3):774-779.
35. McClelland RS, Wang CC, Mandaliya K, et al.: Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 2001;15(1):105-110.
36. Kissinger P, Amedee A, Clark RA, et al.: Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis 2009;36(1):11-16.
37. Cohen CR, Moscicki AB, Scott ME, et al.: Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa. AIDS 2010;24(13):2069- 2074.
38. Zhou X, Brown CJ, Abdo Z, et al.: Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J 2007;1(2):121-133.
39. Delany S, Mlaba N, Clayton T, et al.: Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: A randomized placebo-controlled trial in South Africa. AIDS 2009;23(4):461-469.
40. Tanton C, Weiss HA, Le Goff J, et al.: Correlates of HIV-1 genital shedding in Tanzanian women. PLoS One 2011;6(3): e17480.